Paper14400
Glutamine synthetase: glial localization in brain.
Martinez-Hernandez A and 2 others. Science, 1977. Cited by 1,000 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glutamine synthetase: glial localization in brain. Papers, record 14400. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14400
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Glutamate-Ammonia Ligase | Major topic |
| Neuroglia | Major topic |
| Ammonia | |
| Animals | |
| Glutamates | |
| Immunoenzyme Techniques | |
| Rats | |
| gamma-Aminobutyric Acid |
Source PubMed
Cited by329
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,000 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,652,481 | Bioactivity and Molecular Responses of Bitter Gourd Leaf Extracts Against the Invasive Leafminer, Liriomyza trifolii (Diptera: Agromyzidae). | Insects | 2026 | https://conductscience.org/library/papers/42652481 | PubMed |
| 40,629,476 | From the different pathogenesis of epileptogenesis: vitamins as an adjunctive treatment for epilepsy. | Acta Epileptol | 2025 | https://conductscience.org/library/papers/40629476 | PubMed |
| 40,500,498 | An Overview of Oligodendrocyte Metabolism. | Adv Neurobiol | 2025 | https://conductscience.org/library/papers/40500498 | PubMed |
| 40,066,661 | The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances. | J Neurochem | 2025 | https://conductscience.org/library/papers/40066661 | PubMed |
| 39,259,492 | Disrupted glutamate homeostasis as a target for glioma therapy. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/39259492 | PubMed |
| 39,195,276 | The Role of Astrocytes in CNS Disorders: Historic and Contemporary Views. | Cells | 2024 | https://conductscience.org/library/papers/39195276 | PubMed |
| 39,073,381 | Identification of neurotransmitter imbalances in the cingulate cortex of NMOSD patients using magnetic resonance spectroscopy. | Cereb Cortex | 2024 | https://conductscience.org/library/papers/39073381 | PubMed |
| 38,992,696 | CPEB2-activated axonal translation of VGLUT2 mRNA promotes glutamatergic transmission and presynaptic plasticity. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38992696 | PubMed |
| 38,838,644 | Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency. | Cell Metab | 2024 | https://conductscience.org/library/papers/38838644 | PubMed |
| 38,785,950 | Interplay between Energy Supply and Glutamate Toxicity in the Primary Cortical Culture. | Biomolecules | 2024 | https://conductscience.org/library/papers/38785950 | PubMed |
| 38,655,199 | Tet controls axon guidance in early brain development through glutamatergic signaling. | iScience | 2024 | https://conductscience.org/library/papers/38655199 | PubMed |
| 38,584,983 | A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB's and Ceftriaxone. | Ann Neurosci | 2024 | https://conductscience.org/library/papers/38584983 | PubMed |
| 38,572,151 | Diffusion of brain metabolites highlights altered brain microstructure in type C hepatic encephalopathy: a 9.4 T preliminary study. | Front Neurosci | 2024 | https://conductscience.org/library/papers/38572151 | PubMed |
| 38,474,295 | Astrocyte-Neuron Interaction via the Glutamate-Glutamine Cycle and Its Dysfunction in Tau-Dependent Neurodegeneration. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474295 | PubMed |
| 38,424,459 | Assessment of a one-week ketogenic diet on brain glycolytic metabolism and on the status epilepticus stage of a lithium-pilocarpine rat model. | Sci Rep | 2024 | https://conductscience.org/library/papers/38424459 | PubMed |
| 38,183,680 | Brain energy metabolism: A roadmap for future research. | J Neurochem | 2024 | https://conductscience.org/library/papers/38183680 | PubMed |
| 38,139,462 | Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139462 | PubMed |
| 37,764,736 | Targeting Glutamate Neurotoxicity through Dietary Manipulation: Potential Treatment for Migraine. | Nutrients | 2023 | https://conductscience.org/library/papers/37764736 | PubMed |
| 37,606,786 | Lessons on brain edema in HE: from cellular to animal models and clinical studies. | Metab Brain Dis | 2024 | https://conductscience.org/library/papers/37606786 | PubMed |
| 37,588,272 | Safety of general anaesthetics on the developing brain: are we there yet? | BJA Open | 2022 | https://conductscience.org/library/papers/37588272 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLUL | 2,752 | PubTator's text mining | https://conductscience.org/library/genes/2752 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14400
GET https://conductscience.org/api/papers/v1/14400/cited_by?page=2